Amlodipine Besylate Controlled-Relesae Tablets( Overseas Pharma)
苯磺酸氨氯地平控释片（越洋医药）
Report date: 2025/08/15 14:33:28
Base Information
Drug NameAmlodipine Besylate Controlled-Relesae Tablets( Overseas Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A